More than 120 industry players are engaged in evaluating the potential
Added: (Fri Aug 06 2021)
Pressbox (Press Release) -
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.
To order this 500+ page report, which features 185+ figures and 220+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html
The USD 8.5 billion (by 2030) financial opportunity within the stem cell therapies market has been analyzed across the following segments:
Source of stem cell
Allogeneic
Autologous
Origin of stem cell
Adult
Embryonic
Type of stem cell
Hematopoietic
Mesenchymal
Progenitor
Others
Lineage of stem cell
Adipose Tissue
Bone Marrow
Cord Blood
Others
Route of Administration
Intraarticular
Intracoronary
Intramuscular
Intramyocardial
Intrathecal
Intravenous
Surgical Implantations
Others
Therapeutic Area
Autoimmune / Inflammatory Disorder
Cardiovascular Disorders
Metabolic Disorder
Musculoskeletal Disorders
Oncological Disorders
Neurological Disorders
Ophthalmic Disorders
Others
End Users
Ambulatory Surgery Centers
Hospitals
Specialty Clinics
Key Geographies
North America
Europe
Asia-Pacific and Rest of the World
The Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”. report features the following companies, which we identified to be key players in this domain:
To request for sample report - https://www.rootsanalysis.com/reports/296/request-sample.html
Anterogen
Athersys
CHABiotech
Cytopeutics
Hope Biosciences
Japan Regenerative Medicine
Lineage Cell Therapeutics
Orchard Therapeutics
Osiris Therapeutics
Pluristem Therapeutics
Promithera Biosciences
Regenexx
Stempeutics Research
SCM Life Sciences
TICEBA
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Key Therapeutic Areas
7. Assessment of Relative Competition and Growth Opportunities
8. Academic Grants Analysis
9. Clinical Trail Analysis
10. Stem Cell Manufacturing Market Landscape and KPIs for Evaluating Contract
Services Partners
11. Stem Cell Therapy Developers and CMOs: Opportunity Assessment
12. Key Commercialization Strategies
13. Market Forecast
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis